Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Rational development of addiction pharmacotherapies: successes, failures, and prospects.

Pierce RC, O'Brien CP, Kenny PJ, Vanderschuren LJ.

Cold Spring Harb Perspect Med. 2012 Jun;2(6):a012880. doi: 10.1101/cshperspect.a012880. Review.

2.

Medications for substance use disorders.

Douaihy AB, Kelly TM, Sullivan C.

Soc Work Public Health. 2013;28(3-4):264-78. doi: 10.1080/19371918.2013.759031. Review.

3.

Evidence-based pharmacological treatment of substance use disorders and pathological gambling.

van den Brink W.

Curr Drug Abuse Rev. 2012 Mar;5(1):3-31. Review.

PMID:
22126708
4.

Pharmacotherapy for Substance Use Disorders.

Klein JW.

Med Clin North Am. 2016 Jul;100(4):891-910. doi: 10.1016/j.mcna.2016.03.011. Epub 2016 Apr 20. Review.

PMID:
27235620
5.

A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders.

Gastfriend DR.

Ann N Y Acad Sci. 2014 Oct;1327:112-30. doi: 10.1111/nyas.12538. Epub 2014 Sep 18. Review.

6.

Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.

Heidbreder CA, Hagan JJ.

Curr Opin Pharmacol. 2005 Feb;5(1):107-18. Review.

PMID:
15661634
7.

Addiction pharmacotherapy 2000: new options, new challenges.

Rawson RA, McCann MJ, Hasson AJ, Ling W.

J Psychoactive Drugs. 2000 Oct-Dec;32(4):371-8. Review.

PMID:
11210198
8.

Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.

Oliva EM, Maisel NC, Gordon AJ, Harris AH.

Curr Psychiatry Rep. 2011 Oct;13(5):374-81. doi: 10.1007/s11920-011-0222-2. Review.

9.

Pharmacotherapies for adolescent substance use disorders.

Simkin DR, Grenoble S.

Child Adolesc Psychiatr Clin N Am. 2010 Jul;19(3):591-608. doi: 10.1016/j.chc.2010.03.010. Review.

PMID:
20682223
10.

New horizons for therapeutics in drug and alcohol abuse.

Jupp B, Lawrence AJ.

Pharmacol Ther. 2010 Jan;125(1):138-68. doi: 10.1016/j.pharmthera.2009.11.002. Epub 2009 Nov 14. Review.

PMID:
19917308
11.

Current pharmacotherapies of alcoholism: a U.S. perspective.

Anton RF, Swift RM.

Am J Addict. 2003;12 Suppl 1:S53-68. Review.

PMID:
14972780
12.

Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research.

Kranzler HR.

Alcohol Alcohol. 2000 Nov-Dec;35(6):537-47. Review.

PMID:
11093959
13.

Rational treatment of addiction.

Terenius L.

Curr Opin Chem Biol. 1998 Aug;2(4):541-7. Review.

PMID:
9736929
14.

Pharmacologic treatments for drug and alcohol dependence.

Kranzler HR, Amin H, Modesto-Lowe V, Oncken C.

Psychiatr Clin North Am. 1999 Jun;22(2):401-23. Review.

PMID:
10385941
15.

Pharmacotherapies for alcoholism: the old and the new.

Olive MF.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):2-4.

PMID:
20232494
16.

Prevention of relapse to addiction: information for the practitioner.

Wilcox RE, Erikson CK.

Tex Med. 2004 Feb;100(2):52-61. Review.

PMID:
15146782
17.

Recent advances in the pharmacotherapy of alcoholism.

Myrick H, Anton R.

Curr Psychiatry Rep. 2004 Oct;6(5):332-8. Review.

PMID:
15355755
18.

Pharmacotherapies for treating opioid use disorder.

Nguyen TA, Hahn JH, Strakowski SM.

CNS Spectr. 2013 Dec;18(6):289-95. doi: 10.1017/S1092852913000229. Epub 2013 Apr 8. Review.

PMID:
23561653
19.

Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.

Xi ZX, Gardner EL.

Curr Drug Abuse Rev. 2008 Nov;1(3):303-27. Review.

20.

Clinical uses of naltrexone: a review of the evidence.

Modesto-Lowe V, Van Kirk J.

Exp Clin Psychopharmacol. 2002 Aug;10(3):213-27. Review.

PMID:
12233982

Supplemental Content

Support Center